Supernus Pharmaceuticals | SUPN - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 0.60 0.52 -0.21 May/05
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04
FY2025Q2 Jun/2025 0.40 0.46 0.77 Aug/05
FY2025Q1 Mar/2025 -0.21 0.37 0.26 May/06




Eps Alterar Data
Abbott USD 1.15 0.35 2026-03
ANI Pharmaceuticals USD 2.05 0.28 2026-03
Aurora Cannabis CAD -0.13 0.51 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Canopy Growth CAD -0.4 0.35 2026-03
Cara Therapeutics USD -0.59 4.45 2025-09
Corcept Therapeutics USD -0.3 0.5 2026-03
Eisai JPY -11.53 72.47 2026-03
Eli Lilly USD 8.55 1.01 2026-03
Novo Nordisk DKK 10.91 4.87 2026-03
Pacira USD 0.6 0.54 2026-03
Perrigo USD 0.43 0.34 2026-03
Pfizer USD 0.75 0.09 2026-03
Supernus Pharmaceuticals USD 0.6 0.67 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Xeris Pharmaceuticals USD 0.01 0.04 2026-03